Results 1 to 5 of 5
Page 1 of 1
TypeTitleAuthor(s)YearViews
Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: Pharmacodynamic implicationsZhou, XJ; Lim, SG; Lloyd, DM; Chao, GC; Brown, NA; Lai, CL2006248
 
Final results of a phase I/II dose escalation trial of valtorcitabine in patients with chronic hepatitis BLim, SG; Lai, CL; Myers, M; Yuen, RMF; Wai, CT; Lloyd, D; Pietropalolo, K; Zhou, XJ; Chao, G; Brown, NA2005142
 
A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infectionLai, CL; Lim, SG; Brown, NA; Zhou, XJ; Lloyd, DM; Lee, YM; Yuen, MF; Chao, GC; Myers, MW2004120
 
Valtorcitabine provides potent suppression of hepatitis B virus in patients with chronic hepatitis B: Results of a phase I/II clinical trial.Lai, CL; Brown, NA; Yuen, RMF; Wai, CT; Lloyd, D; Pietropaolo, K; Zhou, XJ; Chao, G; Lim, SG2004163
 
The biological behaviour of human adenoid cystic carcinoma cells transduced with interleukin-2-geneSun, CX; He, RG; Cheung, LK; Zhang, ZY; Chen, WT; Liu, XK; Zhou, XJ; Tang, ZY; Chen, SS2002112
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download